Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$379M |
| 2 |
Starbucks
SBUX
|
+$371M |
| 3 |
APC
Anadarko Petroleum
APC
|
+$287M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$263M |
| 5 |
Tesla
TSLA
|
+$253M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortive
FTV
|
+$1.27B |
| 2 |
ANDV
Andeavor
ANDV
|
+$1.11B |
| 3 |
AET
Aetna Inc
AET
|
+$535M |
| 4 |
Microsoft
MSFT
|
+$350M |
| 5 |
Amazon
AMZN
|
+$290M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.69% |
| 2 | Technology | 13.64% |
| 3 | Financials | 12.49% |
| 4 | Consumer Discretionary | 10.83% |
| 5 | Industrials | 9.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2376
CALL
TechnipFMC
FTI
$29.6B
| $1.45M | ﹤0.01% |
+99,456
| New | +$1.85M |
|
2377
Otter Tail
OTTR
$3.87B
| $1.45M | ﹤0.01% |
29,120
-9,798
| -25% | -$468K |
|
2378
iShares S&P 500 Value ETF
IVE
$50.3B
| $1.44M | ﹤0.01% |
14,253
+948
| +7% | +$104K |
|
|
BELFB
2379
Bel Fuse Inc Class B
BELFB
$3.7B
| $1.44M | ﹤0.01% |
78,204
+41,071
| +111% | +$927K |
|
|
FTCH
2380
DELISTED
Farfetch Limited Class A Ordinary Shares
FTCH
| $1.44M | ﹤0.01% |
81,338
-13,517
| -14% | -$293K |
|
2381
Arcos Dorados Holdings
ARCO
$1.71B
| $1.44M | ﹤0.01% |
186,982
-261,535
| -58% | -$1.86M |
|
2382
Vornado Realty Trust
VNO
$7.39B
| $1.44M | ﹤0.01% |
23,134
-71,970
| -76% | -$4.93M |
|
2383
Donnelley Financial Solutions
DFIN
$1.16B
| $1.43M | ﹤0.01% |
101,795
-452,676
| -82% | -$7.23M |
|
2384
ProQR Therapeutics
PRQR
$326M
| $1.43M | ﹤0.01% |
+90,498
| New | +$1.66M |
|
|
TARO
2385
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
| $1.43M | ﹤0.01% |
16,862
+12,186
| +261% | +$1.17M |
|
2386
PUT
Post Holdings
POST
$3.72B
| $1.43M | ﹤0.01% |
24,448
| – | – |
|
2387
RenaissanceRe
RNR
$13.9B
| $1.43M | ﹤0.01% |
10,656
-31,671
| -75% | -$4.14M |
|
2388
Alpha and Omega Semiconductor
AOSL
$800M
| $1.42M | ﹤0.01% |
139,726
-18,852
| -12% | -$194K |
|
2389
Addus HomeCare
ADUS
$2.28B
| $1.41M | ﹤0.01% |
20,816
-76,362
| -79% | -$5.22M |
|
2390
CALL
Madrigal Pharmaceuticals
MDGL
$12.2B
| $1.41M | ﹤0.01% |
12,500
| – | – |
|
2391
Tyler Technologies
TYL
$14.3B
| $1.4M | ﹤0.01% |
7,554
+6,439
| +577% | +$1.27M |
|
2392
Allison Transmission
ALSN
$10.9B
| $1.4M | ﹤0.01% |
31,912
-617,240
| -95% | -$28.6M |
|
2393
V2X
VVX
$2.43B
| $1.4M | ﹤0.01% |
64,877
-85,210
| -57% | -$2.18M |
|
2394
Liberty Media Series C
FWONK
$26B
| $1.4M | ﹤0.01% |
+47,098
| New | +$1.46M |
|
|
VRTV
2395
DELISTED
VERITIV CORPORATION
VRTV
| $1.4M | ﹤0.01% |
55,893
+38,725
| +226% | +$1.18M |
|
2396
Invesco S&P 500 Low Volatility ETF
SPLV
$7.11B
| $1.4M | ﹤0.01% |
29,897
-10,153
| -25% | -$492K |
|
2397
PUT
Biogen
BIIB
$32.5B
| $1.38M | ﹤0.01% |
4,600
| – | – |
|
2398
Jefferies Financial Group
JEF
$12.3B
| $1.38M | ﹤0.01% |
89,071
-466,276
| -84% | -$8.54M |
|
2399
First Trust Industrials/Producer Durables AlphaDEX Fund
FXR
$747M
| $1.38M | ﹤0.01% |
+40,396
| New | +$1.52M |
|
2400
iShares MSCI Germany ETF
EWG
$1.73B
| $1.37M | ﹤0.01% |
54,206
-115,987
| -68% | -$3.14M |
|
Similar funds
Israel Englander's Q4 2018 Portfolio in Review
As of Q4 2018, Israel Englander held 4,541 positions worth $64.1B, down 21% from $81.6B the previous quarter. Its ten largest holdings account for 6.7% of the portfolio.
Israel Englander withdrew a net $4.25B in Q4 2018, closing 844 positions and reducing 1,571 holdings. Its most notable exit was Andeavor, an estimated $1.11B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 12% a quarter earlier, followed by Technology and Financials.
Against the trend, Israel Englander opened a new position in Athenahealth, Inc. worth $135M.
- Israel Englander's largest Q4 2018 buy was Athenahealth, Inc.: 1,022,505 shares worth $135M.
- Israel Englander added most to Celgene Corp in Q4 2018, an estimated $379M increase.
- Israel Englander's biggest Q4 2018 reduction was Fortive, cutting an estimated $1.27B.
- Israel Englander fully exited Andeavor in Q4 2018, selling an estimated $1.11B.
- Israel Englander's ten largest holdings make up 6.7% of its $64.1B portfolio in Q4 2018.
- Israel Englander opened 702 new positions and closed 844 in Q4 2018.
- Israel Englander's portfolio value fell 21% quarter-over-quarter to $64.1B.
Based on Millennium Management's 13F filing for Q4 2018, filed 14 Feb 2019.